BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14659307)

  • 1. Socioeconomic status & returning for a second screen in the Ontario breast screening program.
    Tatla RK; Paszat LF; Bondy SJ; Chen Z; Chiarelli AM; Mai V
    Breast; 2003 Aug; 12(4):237-46. PubMed ID: 14659307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-positive result and reattendance in the Ontario Breast Screening Program.
    Chiarelli AM; Moravan V; Halapy E; Majpruz V; Mai V; Tatla RK
    J Med Screen; 2003; 10(3):129-33. PubMed ID: 14561264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organized breast screening improves reattendance compared to physician referral: a case control study.
    Makedonov I; Gu S; Paszat LF;
    BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain).
    Borràs JM; Guillen M; Sánchez V; Juncà S; Vicente R
    Eur J Cancer Prev; 1999 Oct; 8(5):427-34. PubMed ID: 10548398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contradictions in women's health care provision: a case study of attendance for breast cancer screening.
    Ross NA; Rosenberg MW; Pross DC; Bass B
    Soc Sci Med; 1994 Oct; 39(8):1015-25. PubMed ID: 7809655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of attendance at a relocatable mammography service for rural women.
    Cockburn J; Sutherland M; Cappiello M; Hevern M
    Aust N Z J Public Health; 1997 Dec; 21(7):739-42. PubMed ID: 9489192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.
    Silva TB; Mauad EC; Carvalho AL; Jacobs LA; Shulman LN
    Rural Remote Health; 2013; 13(2):2321. PubMed ID: 23597169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated with Adherence to Routine Screening Mammography in HIV-Infected Women.
    Weinstein ZM; Battaglia TA; Baranoski AS
    J Womens Health (Larchmt); 2016 May; 25(5):473-9. PubMed ID: 27168388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of returning for second round screening at a population based mammographic screening programme in Melbourne, Australia.
    Cockburn J; Schofield P; White V; Hill D; Russell I
    J Epidemiol Community Health; 1997 Feb; 51(1):62-6. PubMed ID: 9135790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States.
    Katz SJ; Hofer TP
    JAMA; 1994 Aug; 272(7):530-4. PubMed ID: 8046807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer screening and family history among rural women in Wisconsin.
    Lippert MT; Eaker ED; Vierkant RA; Remington PL
    Cancer Detect Prev; 1999; 23(3):265-72. PubMed ID: 10337006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast cancer screening in thirteen French departments].
    Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Dialla PO; Pornet C; Poillot ML; Soler-Michel P; Sarlin N; Lunaud P; Desmidt P; Paré E; Mathis C; Rymzhanova R; Kuntz-Huon J; Exbrayat C; Bataillard A; Régnier V; Kalecinski J; Quantin C; Dumas A; Gentil J; Amiel P; Chauvin F; Dancourt V; Arveux P
    Bull Cancer; 2015 Feb; 102(2):126-38. PubMed ID: 25636359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening among women in Thailand: analyses of population-based household surveys.
    Mukem S; Sriplung H; McNeil E; Tangcharoensathien V
    J Med Assoc Thai; 2014 Nov; 97(11):1106-18. PubMed ID: 25675674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
    Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
    Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening attitudes and behaviors of rural and urban women.
    Bryant H; Mah Z
    Prev Med; 1992 Jul; 21(4):405-18. PubMed ID: 1409484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the use of percutaneous biopsy for diagnosis of breast abnormalities in Ontario.
    Holloway CM; Saskin R; Brackstone M; Paszat L
    Ann Surg Oncol; 2007 Oct; 14(10):2932-9. PubMed ID: 17619931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the use of mammography: the Ontario Health Survey.
    Mercer SL; Goel V
    Cancer Prev Control; 1997 Jun; 1(2):144-51. PubMed ID: 9765738
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of socio-economic status on breast cancer screening in women with diabetes: a population-based study.
    Chan W; Yun L; Austin PC; Jaakkimainen RL; Booth GL; Hux J; Rochon PA; Lipscombe LL
    Diabet Med; 2014 Jul; 31(7):806-12. PubMed ID: 24588332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program.
    Gold N; Christensen RAG; Arneja J; Aminoleslami A; Anderson GM; Brooks JD
    Breast Cancer Res Treat; 2023 Apr; 198(3):523-533. PubMed ID: 36800117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.